Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by stockprospon Oct 28, 2014 9:23am

147 Views

Post# 23067092

RE:RE:Big Pharma Profit

And I would imagine health care insurance would play a large role here too.

Still wondering about my initial thought though. Interesting article below on this that I found. Something to keep in mind if indeed this proves successful (and I really hope it does), what does it mean from a broader cancer treatment market perspective. This would be a loss of multi-billions for government, workers, etc but very justified in my opinion.

Don't want to put the cart before the horse too much, just thinking out loud..

Might ask Roger about this one.

https://healthimpactnews.com/2014/cancer-vaccines-the-next-huge-market-for-big-pharma-depends-on-no-cures-for-cancer/

Bullboard Posts

Eminent acquires promising Nevada gold project